Boston Angel Investors →
Napa Summit 2013 →
Managing Director, GlobalSmartEnergy
Professor, Laboratory of Genetics, Salk Institute
Co-Chair, Life Sciences Practice, Fenwick and West
Founder and Managing Director, Lead Dog Ventures
President and CEO, PATH
Founder, Gilt Groupe
General Partner, Flybridge Capital Partners
ACT is testing a therapy derived from human embryonic stem cells.
San Francisco · 6/3/13
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.
© 2007-2013, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.